CAPTRUST Financial Advisors
VIVO

CAPTRUST Financial Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,397
Closed -$246K – 2415
2022
Q4 		$246K Sell
7,397
-43
-0.6% -$1.39K ﹤0.01% 1816
2022
Q3 		$235K Sell
7,440
-442
-6% -$14.3K ﹤0.01% 1721
2022
Q2 		$240K Buy
7,882
+100
+1% +$2.7K ﹤0.01% 1567
2022
Q1 		$202K Buy
7,782
+1,495
+24% +$35.6K ﹤0.01% 1720
2021
Q4 		$128K Sell
6,287
-231
-4% -$4.43K ﹤0.01% 1964
2021
Q3 		$125K Sell
6,518
-537
-8% -$10.7K ﹤0.01% 1895
2021
Q2 		$156K Buy
7,055
+389
+6% +$8.25K ﹤0.01% 1699
2021
Q1 		$175K Buy
6,666
+4,816
+260% +$115K ﹤0.01% 1565
2020
Q4 		$35K Buy
1,850
+80
+5% +$1.49K ﹤0.01% 1999
2020
Q3 		$30K Hold
1,770
– – ﹤0.01% 1810
2020
Q2 		$40K Buy
+1,770
New +$25.7K ﹤0.01% 1707
2019
Q4 		– Sell
-4,430
Closed -$42K – 1936
2019
Q3 		$42K Sell
4,430
-4,530
-51% -$47.7K ﹤0.01% 1055
2019
Q2 		$106K Hold
8,960
– – ﹤0.01% 744
2019
Q1 		$158K Hold
8,960
– – 0.01% 569
2018
Q4 		$156K Hold
8,960
– – 0.01% 478
2018
Q3 		$134K Buy
+8,960
New +$139K 0.01% 516

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CAPTRUST Financial Advisors's VIVO Position: Q1 2023 in Review

CAPTRUST Financial Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,397 shares — an estimated $246K sold.

CAPTRUST Financial Advisors first reported a position in VIVO in Q3 2018 and held it in 16 quarters. The position peaked at $246K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • CAPTRUST Financial Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 7,397 Meridian Bioscience Inc shares in Q1 2023, an estimated $246K.
  • CAPTRUST Financial Advisors first reported a position in Meridian Bioscience Inc in Q3 2018 and held it in 16 quarters.
  • CAPTRUST Financial Advisors's Meridian Bioscience Inc position peaked at $246K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2023, filed 15 May 2023.